Efficacy of amodiaquine for uncomplicated Plasmodium falciparum malaria in Harper, Liberia

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 96, Issue 6, 2002, Pages 670-673

  Checchi, F ^a,e   Balkan, S ^a   Vonhm, B T ^b   Massaquoi, M ^a   Biberson, P ^a   Eldin de Pecoulas, P ^c   Brasseur, P ^d   Guthmann, Jean Paul ^e  

^a MÉDECINS SANS FRONTIÈRES   (Switzerland)

^b MINISTRY OF HEALTH AND SOCIAL WELFARE   (Liberia)

^c Laboratoire de Parasitologie   (France)

^d UNIVERSITÉ DE ROUEN   (France)

^e EPICENTRE   (France)

Author keywords

Amodiaquine; Chemotherapy; Liberia; Malaria; Plasmodium falciparum; Resistance

Indexed keywords

AMODIAQUINE; ANTIMALARIAL AGENT; ARTESUNATE; CHLOROQUINE; FANSIDAR;

ANTIBIOTIC RESISTANCE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; FEMALE; GENOTYPE; HUMAN; IN VIVO STUDY; INFANT; LIBERIA; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; MEDICAL INFORMATION; PARASITOLOGY; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; REINFECTION; TREATMENT FAILURE; TREATMENT OUTCOME; VOMITING;

PLASMODIUM FALCIPARUM; PROTOZOA;

EID: 0036881091     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-9203(02)90348-2     Document Type: Article

References (20)

1. Basco, L. K. (1991). Inefficacy of amodiaquine against chloroquine-resistant malaria. Lancet, 33, 1460.
2. Basco, L. K. & Ringwald, P. (2000). Molecular epidemiology of malaria in Yaounde, Cameroon. VII. Analysis of recrudescence and reinfection in patients with uncomplicated falciparum malaria. American Journal of Tropical Medicine and Hygiene, 63, 215-221.
3. Bloland, P. B. (2001). Drug resistance in malaria. Geneva: World Health Organization, WHO/CDS/CSR/DRS/2001.4.
4. Brasseur, P., Guiguemde, R., Diallo, S., Guiyedi, V., Kombila, M., Ringwald, P. & Olliaro, P. (1999). Amodiaquine remains effective for treating uncomplicated malaria in West and Central Africa. Transactions of the Royal Society of Tropical Medicine and Hygiene, 93, 645-650.
5. Checchi, F., Durand, R., Balkan, S., Vonhm, B. T., Kollie, J. Z., Biberson, P., Baron, E., Le Bras, J. & Guthmann, J.-P. (2002). High Plasmodium falciparum resistance to chloroquine and sulfadoxine-pyrimethamine in Harper, Liberia: results in vivo and analysis of point mutations. Transactions of the Royal Society of Tropical Medicine and Hygiene, 96, 664-669.
6. D'Alessandro, U. & Buttiëns, H. (2001). History and importance of antimalarial drug resistance. Tropical Medicine and International Health, 6, 845-848.
7. Felger, I., Irion, A., Steiger, S. & Beck, H. P. (1999). Epidemiology of multiple Plasmodium falciparium infections. Genotypes of merozoite surface protein 2 of Plasmodium falciparum in Tanzania. Transactions of the Royal Society of Tropical Medicine and Hygiene, 93, supplement 1, S1/3-S1/9.
8. Gorissen, E., Ashruf, G., Lamboo, M., Bennebroek, J., Gikunda, S., Mbaruku, G. & Kager, P. A. (2000). In vivo efficacy study of amodiaquine and sulfadoxine/pyrimethamine in Kibwezi, Kenya and Kigoma, Tanzania. Tropical Medicine and International Health, 5, 459-463.
9. Mutabingwa, T., Nzila, A., Mberu, E., Nduati, E., Winstanley, P., Hills, E. & Watkins, W. (2001). Chlorproguanildapsone for treatment of drug-resistant falciparum malaria in Tanzania. Lancet, 358, 1218-1223.
10. Nevill, C. G., Verhoeff, F. H., Munafu, C. G., ten Howe, W. R., van der Kaay, H. J. & Were, J. B. (1994). A comparison of amodiaquine and chloroquine in the treatment therapy of falciparum malaria in Kenya. East African Medical Journal, 71, 167-170.
11. Olliaro, P., Nevill, C., Le Bras, J., Ringwald, P., Mussano, P., Garner, P. & Brasseur, P. (1996). Systematic review of amodiaquine treatment in uncomplicated malaria. Lancet, 348, 1196-1201.
12. Orrell, C., Taylor, W. R. J. & Olliaro, P. (2001). Acute asymptomatic hepatitis in a healthy normal volunteer exposed to 2 oral doses of amodiaquine and artesunate. Transactions of the Royal Society of Tropical Medicine and Hygiene, 95, 517-518.
13. Rønn, A. M., Msangeni, H. A., Mhina, J., Wernsdorfer, W. H. & Bygbjerg, I. C. (1996). High level of resistance of Plasmodium falciparum to sulphadoxine-pyrimethamine in children in Tanzania. Transactions of the Royal Society of Tropical Medicine and Hygiene, 90, 179-181.
14. Staedke, S. G., Kamya, M. R., Dorsey, G., Gasasira, A., Ndeezi, G., Charlebois, E. D. & Rosenthal, P. J. (2001). Amodiaquine, sulfadoxine/pyrimethamine, and combination therapy for treatment of uncomplicated falciparum malaria in Kampala, Uganda: a randomised trial. Lancet, 358, 368-374.
15. White, N. J. (1996). Can amodiaquine be resurrected? Lancet, 348,1184.
16. White, N. J. & Olliaro, P. (1996). Strategies for the prevention of antimalarial drug resistance: rationale for combination chemotherapy for malaria. Parasitology Today, 12, 399-401.
17. White, N. J., Nosten, F., Looareesuwan, S., Watkins, W. M., Marsh, K., Snow, R. W., Kokwaro, G., Ouma, J., Hien, T. T., Molyneux, M. E., Taylor, T. E., Newbold, C. I., Ruebush, T. K., Danis, M., Greenwood, B. M., Anderson, R. M. & Olliaro, P. (1999). Averting a malaria disaster. Lancet, 353, 1965-1967.
18. WHO (1996). Assessment of therapeutic efficacy of antimalarial drugs for uncomplicated falciparum malaria in areas with intense transmission. Geneva: World Health Organization, WHO/ MAL/96.1077.
19. WHO (2001a). The use of antimalarial drugs. Geneva: World Health Organization, WHO/CDS/RBM/2001.33.
20. WHO (2001b). Antimalarial drug combination therapy. Geneva: World Health Organization, WHO/CDS/RBM/2001.35.